Plant upgrade to lower supply of Merck's adult HBV shot

01/7/2009 | Philadelphia Inquirer, The

Merck & Co. announced an impending shortage of the adult version of Recombivax HB, its hepatitis B vaccine, because of improvements to its West Point, Pa., facility. The shortfall does not include the pediatric formulation and is not linked to an FDA warning issued in April about production issues at the plant, a Merck spokeswoman said. GlaxoSmithKline is making enough vaccines to address the shortage, the CDC said.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC